| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |